Literature DB >> 10580955

Wegener granulomatosis: MR imaging findings in brain and meninges.

J M Murphy1, B Gomez-Anson, J H Gillard, N M Antoun, J Cross, J D Elliott, M Lockwood.   

Abstract

PURPOSE: To determine the spectrum of intracranial magnetic resonance (MR) imaging appearances of Wegener granulomatosis.
MATERIALS AND METHODS: MR imaging studies in 19 patients with Wegener granulomatosis and possible central nervous system involvement were reviewed by two neuroradiologists. Intermediate-weighted and T2-weighted fast spin-echo MR images of the brain had been acquired in all patients, and spin-echo T1-weighted nonenhanced and gadolinium-enhanced images had been acquired in 18 patients.
RESULTS: MR imaging findings included diffuse linear dural thickening and enhancement (n = 6); focal dural thickening and enhancement contiguous with orbital, nasal, or paranasal disease (n = 5); infarcts (n = 4); nonspecific white matter areas of high signal intensity on intermediate-weighted and T2-weighted images (n = 10); enlarged pituitary gland with infundibular thickening and enhancement (n = 2); a discrete cerebellar lesion that was probably granulomatous in origin (n = 1); and cerebral (n = 8) and cerebellar atrophy (n = 2).
CONCLUSION: MR imaging demonstrated the wide spectrum of findings of central nervous system involvement in patients with Wegener granulomatosis and was particularly useful for the evaluation of direct intracranial spread from orbital, nasal, or paranasal disease.

Entities:  

Mesh:

Year:  1999        PMID: 10580955     DOI: 10.1148/radiology.213.3.r99dc11794

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  31 in total

Review 1.  Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature.

Authors:  K Warnatz; H H Peter; M Schumacher; L Wiese; A Prasse; F Petschner; P Vaith; B Volk; S M Weiner
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  MR Imaging in Wegener granulomatosis of the spinal cord.

Authors:  Hans-J Mentzel; Thomas Neumann; Clemens Fitzek; Dieter Sauner; Jürgen R Reichenbach; Werner A Kaiser
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

3.  Pituitary involvement in Wegener's granulomatosis: unusual biochemical findings and severe malnutrition.

Authors:  Carmen Tenorio Jimenez; Amparo Montalvo Valdivieso; Gema López Gallardo; Barbara Mcgowan
Journal:  BMJ Case Rep       Date:  2011-11-07

4.  A review on dural tail sign.

Authors:  Houman Sotoudeh; Hadi Rokni Yazdi
Journal:  World J Radiol       Date:  2010-05-28

5.  Fatal inflammatory hypophysitis.

Authors:  Elizabeth A McIntyre; Petros Perros
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

6.  Combined CNS and pituitary involvement as a primary manifestation of Wegener granulomatosis.

Authors:  Radek Spísek; Elena Kolouchová; Jirí Jensovský; Robert Rusina; Pavel Fendrych; Jaroslav Plas; Jirina Bartůnková
Journal:  Clin Rheumatol       Date:  2005-12-02       Impact factor: 2.980

7.  Atypical meningeal involvement in Wegener granulomatosis: MR imaging survey of a particular case.

Authors:  N Tasali; R Cubuk; L Celik; B Canbora
Journal:  AJNR Am J Neuroradiol       Date:  2009-09       Impact factor: 3.825

8.  Pachymeningitis in granulomatosis with polyangiitis: case series with earlier onset in younger patients and literature review.

Authors:  Violeta Higuera-Ortiz; Abraham Reynoso; Natllely Ruiz; Rosa Delia Delgado-Hernández; Gilberto Gómez-Garza; Luis Felipe Flores-Suárez
Journal:  Clin Rheumatol       Date:  2016-12-23       Impact factor: 2.980

9.  Granulomatosis with polyangiitis masquerading as giant cell arteritis.

Authors:  A McCarthy; M Farrell; T Hedley-Whyte; D McGuone; E Kavanagh; S McNally; M Keogan; N Horgan; T Lynch; K O'Rourke
Journal:  J Neurol       Date:  2013-04-13       Impact factor: 4.849

Review 10.  [Wegener's granulomatosis and microscopic polyangiitis].

Authors:  K de Groot; E Reinhold-Keller
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.